| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10307493 | Schizophrenia Research | 2012 | 6 Pages |
Abstract
These results suggest that PPI is a relatively early vulnerability marker, while changes in other neurophysiological measures may only be detected or affected later during the illness course. Antipsychotic and antidepressant medication may aid in elevating PPI levels and potentially have a neuroprotective effect.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Tim B. Ziermans, Patricia F. Schothorst, Mirjam Sprong, Maurice J.C.M. Magnée, Herman van Engeland, Chantal Kemner,